Literature DB >> 28757637

Intravenous hydroxocobalamin and crystal nephropathy.

Matthieu Legrand1, Vincent Mallet2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28757637     DOI： 10.1038/nrneph.2017.110

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  2 in total

1.  Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients.

Authors:  Matthieu Legrand; Thibault Michel; Michel Daudon; Mourad Benyamina; Axelle Ferry; Sabri Soussi; Véronique Maurel; Maïte Chaussard; Marc Chaouat; Maurice Mimoun; Jérôme Verine; Vincent Mallet; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2016-02-18       Impact factor: 17.440

Review 2.  Crystal nephropathies: mechanisms of crystal-induced kidney injury.

Authors:  Shrikant R Mulay; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2017-02-20       Impact factor: 28.314
  2 in total
  1 in total

1.  Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study.

Authors:  François Dépret; Clément Hoffmann; Laura Daoud; Camille Thieffry; Laure Monplaisir; Jules Creveaux; Djillali Annane; Erika Parmentier; Daniel Mathieu; Sandrine Wiramus; Dominique Demeure DIt Latte; Aubin Kpodji; Julien Textoris; Florian Robin; Kada Klouche; Emmanuel Pontis; Guillaume Schnell; François Barbier; Jean-Michel Constantin; Thomas Clavier; Damien du Cheyron; Nicolas Terzi; Bertrand Sauneuf; Emmanuel Guerot; Thomas Lafon; Alexandre Herbland; Bruno Megarbane; Thomas Leclerc; Vincent Mallet; Romain Pirracchio; Matthieu Legrand
Journal:  Crit Care       Date:  2019-12-23       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.